Smoking Predisposition and Your Genetics

By the ExomeDNA Research Team | Last reviewed May 2026

Smoking status — whether an individual has ever smoked, is a current smoker, or has never smoked — is a categorical behavioral phenotype with a heritable component. Unlike continuous measures of lifetime smoking exposure, smoking status captures the initiation and persistence dimensions of tobacco use as a categorical outcome. Twin studies of smoking initiation estimate heritability in the range of 40–60 percent. Genome-wide analyses of smoking status identify neurological pathways linking inherited variation in dopamine reward signaling, epigenetic regulation, and synaptic development to the likelihood of ever taking up tobacco use.

What is Smoking Status?

Smoking status is typically classified as a categorical variable: never smoker, current smoker, or former smoker (having quit). Some genome-wide analyses use a binary ever/never classification, while others incorporate current versus former smoker distinctions to add granularity. As a research phenotype, smoking status captures whether tobacco use initiation occurred and whether it was sustained — different information from how much a person smoked over their lifetime.

The genetic signals underlying smoking status and lifetime smoking quantity are related but not identical. Smoking status is particularly sensitive to the genetics of initiation — the neurobiological factors that determine whether a person first tries cigarettes and continues — while lifetime smoking quantity additionally reflects genetics of persistence, dependence, and the difficulty of quitting.

Understanding the genetic architecture of smoking status informs both the biology of tobacco use initiation and the population-level patterns of who begins smoking. Large-scale genome-wide analyses have contributed to identifying neurobiological pathways that shape whether inherited biological factors increase the likelihood of ever becoming a smoker. Kichaev et al. (2019) examined smoking status among 27 complex traits analyzed using functional enrichment methods that improve statistical power for identifying genetic signals. (Kichaev et al. 2019)[1]

The genetics behind Smoking Status

The genetic architecture of smoking status involves multiple neurobiological pathways, with the strongest signals concentrated in genes related to dopamine reward processing, epigenetic regulation, synaptic connectivity, and appetite and stress biology.

RASGRF2 (Ras protein-specific guanine nucleotide-releasing factor 2) is the top-ranked genetic signal for smoking status in this analysis. RASGRF2 encodes a guanine nucleotide exchange factor that activates Ras-MAPK signaling in neurons — pathways critical for dopamine receptor signaling and synaptic plasticity in reward circuits. RASGRF2 has appeared in genome-wide analyses of multiple substance use behaviors and alcohol use, consistent with a role in the general neurobiological substrates of reward-seeking behavior. Its appearance as the top signal for smoking status underscores the centrality of dopamine reward biology in tobacco use initiation. (Kichaev et al. 2019)[1]

JADE2 (jade family PHD finger 2) encodes a chromatin-associated protein containing a PHD finger domain that is involved in histone acetylation and epigenetic gene regulation. Epigenetic regulation of gene expression in neurons — particularly through histone modifications — shapes the long-term transcriptional states of reward circuit neurons. JADE2's appearance in smoking status genetics points to epigenetic mechanisms as contributors to smoking initiation predisposition, potentially through regulation of gene expression in dopaminergic or other reward-relevant neuronal populations. (Kichaev et al. 2019)[1]

BARHL2 (BarH-like homeobox 2) is a homeobox transcription factor required for the development and specification of inhibitory neuronal populations. BarH-like factors are important for the identity and connectivity of neurons in brain regions relevant to reward processing and behavioral regulation. Variants near BARHL2 appear across multiple genome-wide smoking analyses — both lifetime exposure and smoking status — suggesting it represents a robust signal in the genetic architecture of tobacco use behavior. (Kichaev et al. 2019)[1]

NUCB2 (nucleobindin 2) encodes the precursor protein for nesfatin-1, a peptide involved in regulating appetite and stress-related feeding behavior. Nesfatin-1 acts in the hypothalamus and brainstem to influence energy balance and emotional regulation, and has connections to dopaminergic reward signaling. NUCB2 variants in the context of smoking status genetics point to an intersection between stress regulation, appetite biology, and the neurobiological circuits underlying tobacco use behavior. (Kichaev et al. 2019)[1]

NYAP2 (neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2) encodes an adaptor protein that activates PI3K/Akt signaling specifically in neurons. PI3K/Akt signaling regulates neuronal survival, axon growth, and synaptic plasticity. NYAP2's appearance in smoking status genetics reflects the contribution of neuronal growth and plasticity pathways to the development of circuits underlying smoking behavior. (Kichaev et al. 2019)[1]

BDNF (brain-derived neurotrophic factor) appears in the gene set for smoking status, consistent with its replicated role in smoking and addiction genetics broadly. BDNF supports the survival and differentiation of dopaminergic neurons and regulates synaptic plasticity in reward circuits. Its presence across multiple smoking-related phenotypes — including smoking status — reflects its foundational role in the neurobiology of reward and behavioral persistence. (Kichaev et al. 2019)[1]

Genome-wide analyses of smoking status identify signals near RASGRF2, JADE2, BARHL2, NUCB2, and NYAP2 — reflecting dopamine reward signaling, epigenetic regulation, neurodevelopment, and stress-appetite biology as contributors to the neurobiological basis of tobacco use initiation. (Kichaev et al. 2019)^[1]

What the research says

Research base: Moderate. Smoking status genetics is supported by genome-wide evidence from multiple studies and ancestries. The moderate confidence tier reflects that smoking behavior — including initiation — is influenced by powerful social and environmental factors alongside genetics, and that individual genetic signals have small effects consistent with a polygenic architecture.

Kichaev et al. (2019) applied a functional enrichment approach (FINDOR) to genome-wide association analyses across 27 complex traits, including smoking status from UK Biobank data. Their method leverages functional annotations to improve statistical power for identifying genetic signals in large biobank-scale datasets. Smoking status was among the traits showing meaningful improvement in detected loci using this approach, contributing to the catalog of genetic signals for tobacco use behavior. (Kichaev et al. 2019)[1]

The broader smoking genetics literature — including studies of smoking initiation, cigarettes per day, and nicotine dependence — consistently identifies dopamine reward pathway genes, GABAergic interneuron development genes, and synaptic biology genes as the core architecture of tobacco use genetics.

Twin studies of smoking initiation estimate heritability at 40–60 percent. Genome-wide research consistently identifies dopamine signaling, GABAergic circuitry, and synaptic plasticity as the primary neurobiological substrates of inherited tobacco use predisposition. (Kichaev et al. 2019)^[1]

How Smoking Status affects you

The ExomeDNA smoking status result reflects polygenic associations with ever/never tobacco use identified in population studies. A higher score is associated with statistically greater likelihood of having ever smoked compared to the population baseline — it does not forecast individual behavior or override the influence of social, environmental, and personal factors on smoking decisions.

Smoking initiation is powerfully shaped by social context, peer influences, tobacco availability, and cultural norms — factors that interact with biological predisposition. The genetic contribution captured here is one layer of a complex behavioral picture in which environmental factors play an equally important role.

This result reflects predisposition to smoking behavior, not to the health consequences of tobacco use. The health impacts of smoking are consistent across genetic backgrounds and operate through mechanisms distinct from the behavioral predisposition genetics captured here.

Working with your profile

What research suggests about factors that interact with smoking status genetics

1. Social and cultural environment — Smoking initiation rates are strongly shaped by peer behavior, social norms, tobacco marketing exposure, and policy environment. The expression of genetic predisposition to smoking initiation is substantially modified by these environmental factors.
2. Stress and emotional regulation — NUCB2 and RASGRF2 signals in this phenotype connect to stress-regulation and reward biology. Evidence-based strategies for stress management and emotional regulation are relevant for addressing the biological pathways that interact with smoking predisposition.
3. Early exposure prevention — Given that initiation is the phenotype captured here, environmental factors during adolescence — when social pressures around tobacco are highest — are particularly relevant for modifying the expression of genetic predisposition.
4. Cessation support after initiation — Evidence-based cessation approaches (nicotine replacement, behavioral support, varenicline) show efficacy across genetic backgrounds. Genetic predisposition to initiation does not limit the potential benefit of cessation support for those who have already begun smoking.

Related traits and genes

Smoking status shares genetic architecture with related behavioral traits in the ExomeDNA profile.

Related Behavioral Traits:

• Lifetime smoking — composite lifetime exposure measure with partially overlapping genetic signals
• Smoking genetics without educational attainment — the education-independent component of smoking genetics
• Alcohol use behavior — overlapping reward pathway signals, including RASGRF2

Cross-category related traits:

• Stress response — NUCB2 connects stress-appetite regulation to smoking status genetics
• ADHD genetic predisposition — shared impulsivity and dopaminergic circuit signals

RASGRF2 appears in both smoking status and lifetime smoking genetics, reflecting its role as a robust neurobiological signal across tobacco use phenotypes. NUCB2 and JADE2 are more specific to the smoking status phenotype, reflecting distinct biological pathways relevant to initiation versus lifetime quantity.

Frequently asked questions

What is the difference between smoking status and lifetime smoking genetics? Smoking status captures whether someone has ever smoked — primarily reflecting the genetics of initiation. Lifetime smoking captures the full history including quantity and duration. These phenotypes correlate but have partially distinct genetic architectures: status is more sensitive to initiation genetics, while lifetime exposure also reflects persistence and cessation biology.

Does a high genetic score mean I will begin smoking if I have not started? No. The score reflects statistical associations with ever/never smoking status in population studies — not a forecast. Social environment, peer exposure, personal choices, and many other factors beyond genetic predisposition shape whether someone begins smoking. Many individuals with higher polygenic predisposition never smoke.

What is RASGRF2 and why does it appear in smoking status genetics? RASGRF2 is a guanine nucleotide exchange factor that activates Ras-MAPK signaling in neurons — a pathway important for dopamine receptor function and synaptic plasticity. Dopamine reward signaling is a key biological substrate for the reinforcing properties of nicotine, making RASGRF2's role in smoking status genetics mechanistically plausible.

Why do stress-related genes like NUCB2 appear in smoking genetics? Nicotine has acute anxiolytic and mood-modulating effects in the brain, which partly explains why stress reactivity and smoking behavior are correlated. NUCB2 encodes the precursor to nesfatin-1, a peptide involved in stress-responsive appetite and reward regulation — a biologically plausible connection to tobacco use initiation in the context of stress.

Can the ExomeDNA smoking status result tell me anything about my risk of tobacco-related disease? The smoking status result reflects genetic predisposition to tobacco use behavior, not to the health consequences of smoking. The health effects of smoking are consistent across genetic backgrounds. This result does not provide information about disease risk — it captures behavioral predisposition only.

References

1. Kichaev G, Bhatia G, Loh PR, et al. (2019). Leveraging polygenic functional enrichment to improve GWAS power. American Journal of Human Genetics. PMID: 30595370.

--- Data sources: GWAS Catalog (NHGRI-EBI, accessed 2026-05-24) · Open Targets Platform (CC0 1.0, accessed 2026-05-24) · ClinVar (NCBI, accessed 2026-05-24)

This page is published by the ExomeDNA Research Team. Last reviewed: 2026-05-24.